• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CTLA-4 共刺激分子介导的 T 细胞激活负调控的时空基础。

Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation.

机构信息

Laboratory for Cell Signaling, RIKEN Research Center for Allergy and Immunology, Yokohama, Kanagawa, Japan.

出版信息

Immunity. 2010 Sep 24;33(3):326-39. doi: 10.1016/j.immuni.2010.09.006.

DOI:10.1016/j.immuni.2010.09.006
PMID:20870175
Abstract

T cell activation is positively and negatively regulated by a pair of costimulatory receptors, CD28 and CTLA-4, respectively. Because these receptors share common ligands, CD80 and CD86, the expression and behavior of CTLA-4 is critical for T cell costimulation regulation. However, in vivo blocking of CD28-mediated costimulation by CTLA-4 and its mechanisms still remain elusive. Here, we demonstrate the dynamic behavior of CTLA-4 in its real-time competition with CD28 at the central-supramolecular activation cluster (cSMAC), resulting in the dislocalization of protein kinase C-θ and CARMA1 scaffolding protein. CTLA-4 translocation to the T cell receptor microclusters and the cSMAC is tightly regulated by its ectodomain size, and its accumulation at the cSMAC is required for its inhibitory function. The CTLA-4-mediated suppression was demonstrated by the in vitro anergy induction in regulatory T cells constitutively expressing CTLA-4. These results show the dynamic mechanism of CTLA-4-mediated T cell suppression at the cSMAC.

摘要

T 细胞的激活受一对共刺激受体 CD28 和 CTLA-4 的正调控和负调控。由于这些受体共享共同的配体 CD80 和 CD86,因此 CTLA-4 的表达和行为对于 T 细胞共刺激调节至关重要。然而,体内 CTLA-4 阻断 CD28 介导的共刺激及其机制仍然难以捉摸。在这里,我们证明了 CTLA-4 在中央超分子激活簇(cSMAC)中与 CD28 的实时竞争中的动态行为,导致蛋白激酶 C-θ和 CARMA1 支架蛋白的去本地化。CTLA-4 易位到 TCR 微簇和 cSMAC 受到其胞外结构域大小的严格调节,其在 cSMAC 中的积累对于其抑制功能是必需的。通过在持续表达 CTLA-4 的调节性 T 细胞中体外诱导无能来证明 CTLA-4 介导的抑制作用。这些结果显示了 CTLA-4 在 cSMAC 介导的 T 细胞抑制的动态机制。

相似文献

1
Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation.CTLA-4 共刺激分子介导的 T 细胞激活负调控的时空基础。
Immunity. 2010 Sep 24;33(3):326-39. doi: 10.1016/j.immuni.2010.09.006.
2
Involvement of CTLA-4 in T-cell anergy induced by staphylococcal enterotoxin A in vitro.CTLA-4在体外葡萄球菌肠毒素A诱导的T细胞无能中的作用。
Mol Immunol. 2004 May;41(1):1-8. doi: 10.1016/j.molimm.2004.03.001.
3
Regulation of CD28 expression on CD8+ T cells by CTLA-4.细胞毒性T淋巴细胞相关抗原4(CTLA-4)对CD8+ T细胞上CD28表达的调节作用
J Leukoc Biol. 2008 Apr;83(4):853-63. doi: 10.1189/jlb.0107065. Epub 2007 Dec 27.
4
A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.一种新型双特异性四价抗体融合蛋白,用于靶向共刺激活性,以激活针对过表达ErbB2/HER2的肿瘤细胞的T细胞。
J Mol Biol. 2005 Mar 11;346(5):1299-311. doi: 10.1016/j.jmb.2004.12.052. Epub 2005 Jan 22.
5
Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.超抗原诱导的人T淋巴细胞增殖不依赖于共刺激分子CD28的配体B7的共刺激作用。
J Immunol. 1993 Feb 1;150(3):726-35.
6
The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.天然配体驱动未致敏和抗原致敏的CD4+及CD8+T细胞中IL-4表达的能力。
Int Immunol. 2005 Jan;17(1):73-83. doi: 10.1093/intimm/dxh188. Epub 2004 Nov 29.
7
CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.活化B细胞上的OX40配体和CD70对T细胞进行不依赖CD28的共刺激。
J Immunol. 1999 Jun 15;162(12):7058-66.
8
Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation.通过TCR-CD28微簇和蛋白激酶Cθ易位对T细胞共刺激的时空调节。
Immunity. 2008 Oct 17;29(4):589-601. doi: 10.1016/j.immuni.2008.08.011. Epub 2008 Oct 9.
9
A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.一种能选择性结合细胞毒性T淋巴细胞相关抗原4(CTLA-4)的突变型B7-1/免疫球蛋白(Ig)融合蛋白可改善抗肿瘤DNA疫苗接种效果并对抗调节性T细胞活性。
Vaccine. 2005 Aug 31;23(37):4553-64. doi: 10.1016/j.vaccine.2005.05.002.
10
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.重组受体介导的T细胞激活:白细胞介素2分泌和受体介导的T细胞增殖需要CD28共刺激,但不影响受体介导的靶细胞裂解。
Cancer Res. 2001 Mar 1;61(5):1976-82.

引用本文的文献

1
Immune Checkpoint Molecules in Hodgkin Lymphoma and Other Hematological Malignancies.霍奇金淋巴瘤及其他血液系统恶性肿瘤中的免疫检查点分子
Cancers (Basel). 2025 Jul 10;17(14):2292. doi: 10.3390/cancers17142292.
2
Unraveling the role of Ctla-4 in intestinal immune homeostasis through a novel Zebrafish model of inflammatory bowel disease.通过新型斑马鱼炎症性肠病模型揭示Ctla-4在肠道免疫稳态中的作用。
Elife. 2025 May 20;13:RP101932. doi: 10.7554/eLife.101932.
3
The diversity of CD8 T cell dysfunction in cancer and viral infection.癌症和病毒感染中CD8 T细胞功能障碍的多样性。
Nat Rev Immunol. 2025 Apr 11. doi: 10.1038/s41577-025-01161-6.
4
Single-cell RNA sequencing of bone marrow reveals the immune response mechanisms of lymphocytes under avian leukosis virus subgroup J infection.骨髓单细胞RNA测序揭示了J亚群禽白血病病毒感染下淋巴细胞的免疫反应机制。
Poult Sci. 2025 May;104(5):104995. doi: 10.1016/j.psj.2025.104995. Epub 2025 Mar 8.
5
Imaging of biphasic signalosomes constructed by checkpoint receptor 2B4 in conventional and chimeric antigen receptor-T cells.检查点受体2B4在传统和嵌合抗原受体T细胞中构建的双相信号小体的成像。
iScience. 2024 Dec 21;28(1):111669. doi: 10.1016/j.isci.2024.111669. eCollection 2025 Jan 17.
6
T Cell Resistance: On the Mechanisms of T Cell Non-activation.T细胞抗性:关于T细胞未激活的机制
Immune Netw. 2024 Dec 19;24(6):e42. doi: 10.4110/in.2024.24.e42. eCollection 2024 Dec.
7
Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence.免疫检查点抑制剂相关的皮肤不良事件:发生机制
Int J Mol Sci. 2024 Dec 26;26(1):88. doi: 10.3390/ijms26010088.
8
Regulatory T Cell Dysfunction in Autoimmune Diseases.自身免疫性疾病中的调节性 T 细胞功能障碍。
Int J Mol Sci. 2024 Jun 29;25(13):7171. doi: 10.3390/ijms25137171.
9
Immunomodulatory Precision: A Narrative Review Exploring the Critical Role of Immune Checkpoint Inhibitors in Cancer Treatment.免疫调节精准度:探索免疫检查点抑制剂在癌症治疗中关键作用的叙述性综述。
Int J Mol Sci. 2024 May 17;25(10):5490. doi: 10.3390/ijms25105490.
10
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors.克服冷肿瘤:免疫检查点抑制剂的联合策略。
Front Immunol. 2024 Mar 13;15:1344272. doi: 10.3389/fimmu.2024.1344272. eCollection 2024.